These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30025721)

  • 1. Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes.
    Alster P; Krzyżanowska E; Koziorowski D; Szlufik S; Różański D; Noskowska J; Mianowicz J; Michno A; Królicki L; Friedman A
    Neurol Neurochir Pol; 2018 Aug; 52(4):459-464. PubMed ID: 30025721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.
    Alster P; Madetko N; Migda B; Nieciecki M; Kutyłowski M; Królicki L; Friedman A
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.
    Respondek G; Grimm MJ; Piot I; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Roeber S; Giese A; Grossman M; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Höglinger GU;
    Mov Disord; 2020 Jan; 35(1):171-176. PubMed ID: 31571273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.
    Eusebio A; Koric L; Félician O; Guedj E; Ceccaldi M; Azulay JP
    Rev Neurol (Paris); 2016; 172(8-9):488-502. PubMed ID: 27561438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
    Boman A; Svensson S; Boxer A; Rojas JC; Seeley WW; Karydas A; Miller B; Kågedal K; Svenningsson P
    J Parkinsons Dis; 2016 Apr; 6(2):307-15. PubMed ID: 27061067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
    Vasilevskaya A; Taghdiri F; Multani N; Anor C; Misquitta K; Houle S; Burke C; Tang-Wai D; Lang AE; Fox S; Slow E; Rusjan P; Tartaglia MC
    Front Neurol; 2020; 11():574. PubMed ID: 32754109
    [No Abstract]   [Full Text] [Related]  

  • 7. Accumulation of Tau Protein, Metabolism and Perfusion-Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS).
    Alster P; Madetko NK; Koziorowski DM; Królicki L; Budrewicz S; Friedman A
    Front Neurol; 2019; 10():101. PubMed ID: 30837933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers.
    Parmera JB; Oliveira MCB; Rodrigues RD; Coutinho AM
    Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):126-136. PubMed ID: 35976324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS).
    Alster P; Madetko-Alster N; Migda A; Migda B; Kutyłowski M; Królicki L; Friedman A
    Neurol Neurochir Pol; 2023; 57(3):229-234. PubMed ID: 36928793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Approach to Atypical Parkinsonian Syndromes.
    McFarland NR
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1117-42. PubMed ID: 27495201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome-A Pilot Study.
    Alster P; Migda B; Madetko N; Duszyńska-Wąs K; Drzewińska A; Charzyńska I; Starczyński M; Szepelska A; Królicki L; Friedman A
    Front Neurol; 2021; 12():630153. PubMed ID: 33613435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)?
    Alster P; Nieciecki M; Koziorowski D; Cacko A; Charzyńska I; Królicki L; Friedman A
    J Clin Neurosci; 2020 Jul; 77():123-127. PubMed ID: 32389545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autonomic Dysfunction in Tauopathies].
    Koga S; Aiba I
    Brain Nerve; 2022 Mar; 74(3):257-262. PubMed ID: 35260524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progressive supranuclear palsy: what's new?].
    Levy R
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Pantelyat A
    Continuum (Minneap Minn); 2022 Oct; 28(5):1364-1378. PubMed ID: 36222770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.